199 related articles for article (PubMed ID: 10374766)
1. Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
Mooney EE; Nogales FF; Tavassoli FA
Hum Pathol; 1999 Jun; 30(6):611-7. PubMed ID: 10374766
[TBL] [Abstract][Full Text] [Related]
2. Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings.
Mooney EE; Nogales FF; Bergeron C; Tavassoli FA
Histopathology; 2002 Aug; 41(2):110-7. PubMed ID: 12147087
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Sertoli-Leydig Cell Tumor with Predominant Heterologous Mucinous Differentiation and Foci of Hepatocytic Differentiation: Case Report and Review of The Literature.
Liang L; Menzin A; Lovecchio JL; Navarro MD
Ann Clin Lab Sci; 2015; 45(3):348-51. PubMed ID: 26116602
[TBL] [Abstract][Full Text] [Related]
4. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
Virk R; Lu D
Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
[TBL] [Abstract][Full Text] [Related]
5. Raised serum alpha-fetoprotein in Sertoli-Leydig cell tumor (androblastoma) of ovary: report of two cases.
Chadha S; Honnebier WJ; Schaberg A
Int J Gynecol Pathol; 1987; 6(1):82-8. PubMed ID: 2437064
[TBL] [Abstract][Full Text] [Related]
6. A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
Al-Hussaini M; Al-Othman Y; Hijazi E; McCluggage WG
Int J Gynecol Pathol; 2018 May; 37(3):275-283. PubMed ID: 28582340
[TBL] [Abstract][Full Text] [Related]
7. Retiform uterine tumours resembling ovarian sex cord tumours. A comparative immunohistochemical study with retiform structures of the female genital tract.
Nogales FF; Stolnicu S; Harilal KR; Mooney E; García-Galvis OF
Histopathology; 2009 Mar; 54(4):471-7. PubMed ID: 19309399
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Sertoli-Leydig cell tumor with retiform pattern.
Moyles K; Chan YF; Hamill J; Massey R
Pathology; 1995 Oct; 27(4):371-3. PubMed ID: 8771159
[TBL] [Abstract][Full Text] [Related]
9. Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
Czernobilsky B; Mamet Y; David MB; Atlas I; Gitstein G; Lifschitz-Mercer B
Int J Gynecol Pathol; 2005 Oct; 24(4):335-40. PubMed ID: 16175078
[TBL] [Abstract][Full Text] [Related]
10. Sertoli-Leydig cell tumor of ovary in children: A report of two cases, including retiform variant.
Sarkar P; Sengupta M; Chatterjee U; Ghosh D
Indian J Pathol Microbiol; 2021; 64(3):559-562. PubMed ID: 34341273
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Sertoli-Leydig cell tumor: a SRY gene-independent pathway of pseudomale gonadal differentiation.
Hittmair A; Zelger BG; Obrist P; Dirnhofer S
Hum Pathol; 1997 Oct; 28(10):1206-10. PubMed ID: 9343329
[TBL] [Abstract][Full Text] [Related]
12. Ovarian sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid sertoli-leydig cell tumors).
McCluggage WG; Young RH
Am J Surg Pathol; 2007 Apr; 31(4):592-7. PubMed ID: 17414107
[TBL] [Abstract][Full Text] [Related]
13. Evidence that Leydig cells in Sertoli-Leydig cell tumors have a reactive rather than a neoplastic profile.
Mooney EE; Man YG; Bratthauer GL; Tavassoli FA
Cancer; 1999 Dec; 86(11):2312-9. PubMed ID: 10590372
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors.
Emerson RE; Wang M; Roth LM; Zheng W; Abdul-Karim FW; Liu F; Ulbright TM; Eble JN; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):368-74. PubMed ID: 17885485
[TBL] [Abstract][Full Text] [Related]
15. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
16. Sertoli-Leydig cell tumor of ovary with heterologous element: a case report.
Kataria SP; Mishra K; Dev G; Tandon R
Indian J Pathol Microbiol; 2005 Oct; 48(4):493-5. PubMed ID: 16366107
[TBL] [Abstract][Full Text] [Related]
17. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract][Full Text] [Related]
18. Bilateral retiform Sertoli-Leydig cell tumour in a bitch. Alpha-inhibin and epithelial membrane antigen as useful tools for differential diagnosis.
Gómez-Laguna J; Millán Y; Reymundo C; Domingo V; Martín de Las Mulas J
J Comp Pathol; 2008; 139(2-3):137-40. PubMed ID: 18620701
[TBL] [Abstract][Full Text] [Related]
19. Histogenetic consideration of ovarian sex cord-stromal tumors analyzed by expression pattern of cytokeratins, vimentin, and laminin. Correlation studies with human gonads.
Park SH; Kim I
Pathol Res Pract; 1994 May; 190(5):449-56. PubMed ID: 7527534
[TBL] [Abstract][Full Text] [Related]
20. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
